Back to Search
SRI NAVEEN SURAPANENI, M.D., M.P.H.
M.D., M.P.H.
Internal Medicine Physician
NPI: 1225120801IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
48602-020(WI)
Education
OTHER
Class of 2003
Research & Publications (20)
In vitro metabolism of the novel, highly selective oral angiogenesis inhibitor motesanib diphosphate in preclinical species and in humans.
PMID 19372226·Drug Metab Dispos·2009
8-other
Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption.
PMID 18543293·J Pharm Sci·2009
7-preclinical
Effect of systemic alcohol and nicotine on airway protective reflexes.
PMID 19550414·Am J Gastroenterol·2009
8-other
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
PMID 18420600·J Pharmacol Exp Ther·2008
4-observational
Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists.
PMID 18386885·J Med Chem·2008
7-preclinical
Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans.
PMID 18337008·Pain·2008
3-trial
The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics.
PMID 18214948·J Pharm Sci·2008
7-preclinical
Biosynthesis of drug metabolites using microbes in hollow fiber cartridge reactors: case study of diclofenac metabolism by Actinoplanes species.
PMID 18006646·Drug Metab Dispos·2008
8-other
Novel vanilloid receptor-1 antagonists: 2. Structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate.
PMID 17585750·J Med Chem·2007
7-preclinical
Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
PMID 17652633·J Pharmacol Exp Ther·2007
7-preclinical
Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties.
PMID 17585751·J Med Chem·2007
7-preclinical
Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.
PMID 17585749·J Med Chem·2007
7-preclinical
The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation.
PMID 17392452·J Neurosci·2007
7-preclinical
Suppressive anti-HCV therapy for prevention of donor to recipient transmission in stem cell transplantation.
PMID 17100972·Am J Gastroenterol·2007
5-case
Identification of a novel in vitro metabonate from liver microsomal incubations.
PMID 16554371·Drug Metab Dispos·2006
7-preclinical
Evaluating the effect of decompression surgery on cerebrospinal fluid flow and intracranial compliance in patients with chiari malformation with magnetic resonance imaging flow studies.
PMID 15574215·Neurosurgery·2004
4-observational
ABT-963 [2-(3,4-difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor.
PMID 15277581·J Pharmacol Exp Ther·2004
7-preclinical
Regional anaesthesia in pre-eclampsia: advantages and disadvantages.
PMID 14871167·Drugs·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1015 MEDICAL CENTER BLVD, SUITE 1700
WEBSTER, TX 77598 - Phone
- (281) 480-6264
Quick Facts
- NPI
- 1225120801
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile